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httpcense.Abstract The incidence of active TB and attendant mortality is increased in patients with impaired
cellular immunity, such as HIV infected patients, solid organ and stem cell transplant recipients and
patients with end-stage renal failure. The relative risk for TB varies with the type of immunodeﬁ-
ciency and mortality rates may be as high as 75%. End-stage renal disease (ESRD) and particularly
uraemia is a known contributor to immunosuppression.
The aim of this work: The aim of this work was to evaluate the increasing risk of pulmonary
tuberculosis among patients with chronic renal failure and the impact of hemodialysis.
Patients and methods: This study was carried at both Nephrology Unit and Chest Department,
Zagazig University Hospitals during the period from April 2012 to Jan 2013. The study included a
total number of 140 patients with chronic renal failure (92 males and 48 females), with mean age of
49 ± 6.4 years. Patients were classiﬁed to three groups: Group 1: Included 40 Patients with chronic
renal failure and not on dialysis. Group 2: Included 50 Patients with chronic renal failure and on
regular hemodialysis three sittings per week for less than 1 year. Group 3: Included 50 Patients with
chronic renal failure and on regular hemodialysis three sittings per week for more than 1 year. All
patients were subjected to: history taking and medical evaluation including general and local3595477.
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188 A.I. Yousef et al.examinations, routine laboratory investigations, Plain chest X-ray; Posteroanterior and lateral
views for all patients, Sputum Ziehl–Neelsen staining and Sputum induction in patients who had
chest X-ray suspecting pulmonary TB without expectoration and Tuberculin skin testing. Selected
cases were subjected to ﬁberoptic bronchoscopy to obtain BAL for ZN staining.
Results: 16 patients (11.4%) proved to have pulmonary tuberculosis by +ve ZN stain for acid
fast bacilli in either sputum or BAL, 28 patients (20%) were suspected to have pulmonary tubercu-
losis by radiological suspension and ve sputum ZN for acid fast bacilli, 6 patients (4.3%) proved
to have extra-pulmonary TB while 90 patients (64.3%) were free from tuberculosis. There were no
signiﬁcant differences among different groups as regards infection by TB.
Conclusion: Patients with chronic renal failure are at increased risk for pulmonary and extra pul-
monary tuberculosis and should be screened routinely and carefully for early detection of TB infec-
tion.
ª 2013 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.Introduction
The incidence of active TB and attendant mortality is in-
creased in patients with impaired cellular immunity, such as
HIV infected patients, solid organ and stem cell transplant
recipients, and patients with end-stage renal failure. The rela-
tive risk for TB varies with the type of immunodeﬁciency
and mortality rates may be as high as 75% [1]. This emphasizes
the particular importance of the cellular arm of the adaptive
immune response for efﬁcient control ofMycobacterium tuber-
culosis [1–4]. Moreover, the presence ofM. tuberculosis-speciﬁc
CD4+ T-cell immunity is used as a surrogate marker for a
previous contact [5]. Despite the availability of highly efﬁca-
cious treatment for TB, it remains a major global health prob-
lem. In 1993, the World Health Organization (WHO) declared
TB a global public health emergency, at a time when an esti-
mated 7–8 million cases and 1.3–1.6 million deaths occurred
each year. In 2010, there were an estimated 8.5–9.2 million
cases and 1.2–1.5 million deaths (including deaths from TB
among HIV-positive people). TB is the second leading cause
of death from an infectious disease worldwide (after HIV,
which caused an estimated 1.8 million deaths in 2008 [6].
It is likely that TB will be seen more frequently in patients
with chronic kidney disease (CKD) as people from the areas of
the world with high background levels of TB are also at in-
creased risk of CKD [7]. Active TB in immuno-compromised
patients can pose a number of challenges. Due to the impaired
immune response, patients maybe clinically oligosymptomatic
in the beginning of active disease, and its diagnosis is often de-
layed due to atypical presentations and more frequent extra-
pulmonary dissemination. Active TB is further aggravated by
a signiﬁcantly higher morbidity due to a more fatal course in
the face of a weakened immune system [1]. In addition, treat-
ment is frequently complicated due to complex drug interac-
tions and altered pharmaco-kinetics [2,4]. End-stage renal
disease (ESRD) and particularly uraemia is a known contrib-
utor to immuno-suppression. The causative factors of the
immunosuppression are complex and disrupt the cell-mediated
immune functions which include identiﬁcation and killing of
intracellular pathogens such as M. tuberculosis [8].
The aim of this work was to evaluate the increasing risk of
pulmonary Tuberculosis among patients with chronic renal
failure and the impact of hemodialysis.Patients and methods
This study was carried at both Nephrology Unit and Chest
Department, Zagazig University Hospitals during the period
from April 2012 to Jan 2013. The study included a total num-
ber of 140 patients with chronic renal failure (92 males and 48
females), with mean age of 49 ± 6.4 years. Patients were clas-
siﬁed to three groups:
- Group 1: Included 40 Patients with chronic renal failure and
not on dialysis.
- Group 2: Included 50 Patients with chronic renal failure and
on regular hemodialysis three sittings per week for less than
1 year.
- Group 3: Included 50 Patients with chronic renal failure and
on regular hemodialysis three sittings per week for more
than 1 year.
All patients were subjected to the following:
(1) History taking and medical evaluation including general
and local examinations.
(2) Laboratory investigations:
 Serum creatinine & blood urea.
 ALT & AST& serum bilirubin & serum albumin.
 Complete Blood Count (CBC).
 Erythrocyte Sedimentation Rate (ESR).
 Fasting & post prandial blood glucose level.
(3) Plain chest X-ray: Postero-anterior and lateral views for
all patients.
(4) Sputum Ziehl–Neelsen staining and Sputum induction
in patients who had chest X-ray suspecting pulmonary
TB without expectoration. The patient was considered
suspect for pulmonary tuberculosis if there were signs
or symptoms consistent with pulmonary tuberculosis
and had radiological picture of the chest consistent with
pulmonary tuberculosis (apical inﬁltrations, cavitations,
calciﬁcations or hilar lymphadenopathy) with ve spu-
tum ZN for acid fast bacilli [9].
(5) Tuberculin skin testing (TST).
(6) Bronchoscopy to obtain BAL for bacteriological exam-
ination for acid fast bacilli in 10 cases in whom Plain
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sputum production and induction of sputum failed to
produce proper sample.
(7) Pleural ﬂuid aspiration and full chemical, bacteriological
and cytological examination in patients presented by
pleural effusion. Abram pleural biopsies were performed
in 4 patients and pleural biopsies were taken by thora-
coscopy in 2 patients.
(8) Excisional cervical lymph node biopsies in 2 cases
presented by cervical lymphadenopathy and sent for
cytological examination.
Statistical analysis
Statistical analysis was performed with SPSS version19
software package (SPSS, Inc. Chicago). P value <0.05 was
considered signiﬁcant.
Results
Table 1 shows that 16 patients (11.4%) were proved to have
pulmonary tuberculosis by +ve sputum ZN for acid fast bacil-
li in 13 patients and +ve ZN in BAL in 3 patients, 28 patients
(20%) were suspected to have pulmonary tuberculosis by
radiological suspension and ve sputum ZN for acid fast ba-
cilli, 6 patients (4.3%) were proved to have extra-pulmonary
TB while 90 patients (64.3%) were free from pulmonary
tuberculosis.
Table 2 shows that there were no signiﬁcant differences
among different groups with sputum zn +ve but there were
signiﬁcant differences among suspected cases in different pa-
tient groups (P< 0.05). 14 patients (28%) in group III wereTable 1 Percentage distribution of all studied patients
according to their infection by Mycobacterium tuberculosis.
N (140) %
Pulmonary TB 16 11.4
Suspect pulmonary TB 28 20
Extra-pulmonary TB 6 4.3
Free from TB 90 64.3
Table 2 Percentage distribution of proved and suspected pulmonar
GI 40 GII 50
N % N
Tuberculous (ZN +ve) 6 15 4
Suspect (ZN ve) 4 10 10
Table 3 Percentage distribution of extra-pulmonary TB in differen
GI 40 GII 50
N % N
Cervical lymphadenitis (2) 1 2.5 0
Plural eﬀusion (4) 2 5 1pulmonary TB suspects, 10 patients (20%) in group II were
pulmonary TB suspects and 4 patients (10%) in group I were
pulmonary TB suspects.
Table 3 shows that 1 patient (2.5%) in group I had TB cer-
vical lymphadenitis and another in the third group also had TB
cervical lymphadenitis. As regards pleural effusion there were
2 patients (5%) in group I versus 1 patient in group II and an-
other in group III.
Table 4 shows that there were 15 patients out of 140
(10.7%) diagnosed to have pleural effusion. 4 Patients out of
15 (26.7%) were tuberculous pleural effusion and 11 patients
(73.3%) were non tuberculous.
Table 5 shows the frequency of each symptom in the three
studied groups. The most common symptom in group I was
weight loss followed by cough and haemoptysis. The most
common symptom in group II was fever followed by weight
loss and cough. The most common symptoms in group III
was cough and haemoptysis followed by weight loss and fever.
There were highly signiﬁcant differences between the three
groups as regards, fever, haemoptysis and weight loss as
P 6 0.001 but there were non signiﬁcant differences between
the three groups as regards cough.
Table 6 shows that there were no signiﬁcant differences
among different groups of patients with sputum ZN+ve as re-
gards chest X-ray. In group I there was one patient (16.6%)
with normal plain chest X-ray, two patients (33.3%) with mild
lesion, two patients (33.3%) with moderate lesion and one pa-
tient (16.6%) with far advanced lesion. In group II there were
two patients (50%) with mild lesion and two patients (50%)
with lesion infection. In group III there was one patient
(16.6%) with normal plain chest X-ray, two patients (33.3%)
with mild lesion, two patients (33.3%) with moderate lesion
and one patient (16.6%) with far advanced lesion.
Table 7 shows that there were no signiﬁcant differences
among different groups of pulmonary tuberculosis patientsTable 4 Percentage distribution of cases of pleural effusion in
patients in different groups (n= 15).
Etiology of pleural eﬀusion N (15) %
Tuberculous 4 26.7
Non uberculous 11 73.3
y TB cases in different patients groups.
GIII 50 X2 P
% N %
8 6 12 2.1 NS
20 14 28 8.4 <0.05
t patient groups.
GIII 50 P
% N %
0 1 2.5 Not computed
2.5 1 2.5 NS
Table 6 Radiological extent of pulmonary TB in patients with sputum ZN +ve.
X-ray picture GI (6) GII (4) GIII (6) X2 P
N % N % N %
Normal 1 16.6 0 0 1 16.6 Fisher’S exact 2.6 NS
Mild 2 33.3 2 50 2 33.3
Moderate 2 33.3 2 50 2 33.3
Far advanced 1 16.6 0 0 1 0
Table 7 Blood urea and serum creatinine levels in tuberculous patients in different groups.
GI (6) GII (4) GIII (6) F P
Blood urea 65 ± 10 88 ± 35 85 ± 32 0.6 NS
Serum creatinin 6.1 ± 2.3 8.5 ± 3.1 31.6 ± 30 1.1 <0.001
Table 9 Percentage distribution of tuberculous patients
according to co-morbidity.
Co-morbid in ZN +ve GI 6 GII 4 GIII 6 P1
N % N % N %
DM 4 66.6 2 50 3 50 <0.05
Hepatic 1 16.7 1 25 2 33.3 <0.05
Cardiac 1 16.7 1 25 1 16.7 NS
P2 <0.05 <0.05 <0.05
Table 5 Percentage distribution of the patients with sputum zn +ve according to their symptoms.
Symptom GI (6) GII (4) GIII (6) X2 P
N % N % N %
Cough 4 66.6 2 50 4 66.6 2.8 NS
Fever 3 50 3 75 2 33.3 16.9 <0.001
Haemoptysis 4 66.6 1 25 4 66.6 21.4 <0.001
Weight loss 5 83 2 50 2 33.3 23.3 <0.001
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ences (P< 0.001) as regards serum creatinine levels with the
highest value in GIII.
Table 8 shows that there were no signiﬁcant differences
among different groups of all studied according to their co-
morbidity. The most common co-morbidity in all groups was
diabetes mellitus as in group I there were 11 patients
(27.5%) who were diabetics, in group II there were 14 patients
(28%)who were diabetics and in group III there were 15 pa-
tients (30%) who were diabetics and theses results are signiﬁ-
cant statistically (P< 0.05). As regards hepatic diseases
there were 7 patients (17.5%) in group I, 13 patients (26%)
in group II and 12 patients (24%) in group III. As regards car-
diac diseases there were 4 patients (10%) in group I, 6 patients
(12%) in group II and 8 patients (18.2%) in group III.
Table 9 shows that there were signiﬁcant differences be-
tween different groups as regards co-morbidity with DM and
hepatic affection. In group I there were 4 patients (66.6%)
who were diabetics and 1 patient (16.7%) was having hepatic
disease. In group II there were 2 patients (50%) who were dia-
betics and 1 patient (25%) was hepatic. In group III there wereTable 8 Percentage distribution of all patients according to
their co-morbidity.
Co-morbidity GI (40) GII (50) GIII (50) P
N % N % N %
DM 11 27.5 14 28 15 30 NS
Hepatic 7 17.5 13 26 12 24 NS
Cardiac 4 10 6 12 8 18.2 NS
P <0.05 <0.05 <0.053 patients (50%) who were diabetics and 2 patients (33.3%)
hepatic. There were non signiﬁcant differences between the
three groups as regard cardiac co-morbidity. Diabetes mellitus
was the most common co-morbid disease in all patient groups
followed by hepatic then cardiac co-morbidity.
Discussion
Patients with End Stage Renal Disease (ESRD) undergoing
chronic dialysis are 6–25 times more likely to develop tubercu-
losis (TB) than the general population, mainly because of the
impaired cellular immunity characteristic of this condition.
Nosocomial transmission of TB has also been reported in
hemodialysis (HD) centers. In a US Renal Data System
(USRDS) retrospective analysis, age, unemployment,
smoking, reduced body mass index, low serum albumin, ische-
mic heart disease, and anemia were all signiﬁcant risk factors
for HD patients to develop TB [10]. End-stage renal disease
(ESRD) and particularly uraemia is a known contributor to
immuno-suppression. The causative factors of the
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immune (CMI) response. T-cells are primarily responsible for
CMI and their functions include identiﬁcation and killing of
intracellular pathogens such as M. tuberculosis. It is the de-
layed type hypersensitivity response of the CMI system that
is responsible for the reaction to the tuberculin skin test.
Therefore, while new methods for determining infection with
TB are developed, identifying risk factors for TB among this
population may aid in developing appropriate counseling
and more targeted screening [8]. There is a 10% increased risk
of TB in the chronic renal failure patients on hemodialysis. It is
likely that the proximity of the patients to each other during
frequent contacts, suboptimal isolation and screening limited
to tuberculin skin test (TST) and chest X-ray (CXR) contrib-
ute to this risk [11].
In our study we have found that 16 patients (11.4%) proved
to have pulmonary tuberculosis by +ve sputum ZN for acid
fast bacilli and 28 patients (20%) were suspected to have pul-
monary tuberculosis by radiological suspension and ve spu-
tum ZN for acid fast bacilli and 6 patients (4.3%) proved to
have extra-pulmonary TB (Table 1 and 2). The sex patients
with extra-pulmonary TB were diagnosed as cervical lymphad-
enitis (2 patients) and pleural effusion (4 patients) (Table 3).
In ESRD, the diagnosis of TB disease is often difﬁcult be-
cause of prevailing extrapulmonary involvement and nonspe-
ciﬁc symptoms. Extrapulmonary TB has been reported in as
many as 60–80% of cases, either alone or associated with
pulmonary TB. The most common forms of presentation are
lymphadenitis, gastrointestinal, bone, genitourinary, peritoni-
tis, pleural effusion, pericardial effusion, miliary TB, and
pyrexia of unknown origin [12]. In immunocompromised
hosts, the presentation of Extrapulmonary TB is often differ-
ent compared to immuno-competent hosts. Dissemination of
the disease is more common and clinicians should be aware
of other localizations. Dissemination is more likely because
ill-formed granulomata are more common in immunocompro-
mised hosts [13].
Hussein et al. 2003, reported that TB is generally diagnosed
in the ﬁrst year after beginning dialysis, and this is attributed
to the seriously impaired host defense mechanism in these
patients during the initial dialysis period [14].
In our study there were no signiﬁcant differences among
different groups with sputum zn +ve but there were signiﬁcant
differences among suspected cases in different patient groups
(P< 0.05) as the numbers of suspected TB cases were more
in group three in whom dialysis was performed for more than
1 year (Table 2).
Atypical manifestations of the disease are observed in 20–
22% of cases [15].
In our study there were highly signiﬁcant differences be-
tween different groups as regards, fever, haemoptysis and
weight loss as P< 0.001 but there were non signiﬁcant differ-
ences between the three groups as regards cough. The most
common symptom in group I were weight loss followed by
cough and haemoptysis. The most common symptom in group
II was fever followed by weight loss and cough. The most com-
mon symptoms in group III were cough and haemoptysis
followed by weight loss and fever (Table 5).
The possibility of TB should always be considered in any
patient with a chronic cough, unexplained weight loss or night
sweats, a cloudy peritoneal dialysate, lymphadenopathy or
chronic site-speciﬁc symptoms. Appearances on a chestradiograph should be compared with previous ﬁlms and, if
new abnormalities are present, advice should be sought from
a respiratory physician. Every effort should be made to obtain
a specimen for culture and sensitivity. Histological Appear-
ances of granulomata, with or without caseation or necrosis,
are helpful [16]. Uremia is commonly associated with fatigue,
mal-nutrition, and other nonspeciﬁc complaints, possibly con-
cealing the course of an underlying TB disease. This atypical
presentation may often lead to a delay in accurate diagnosis
and therapy, sometimes resulting in patient death. Therefore,
nephrologists should always have a high degree of suspicion
and consider the possibility of TB whenever confronted with
an ESRD patient presenting with general symptoms such as fe-
ver, weight loss, and/or lymphadenopathy. The diagnosis
would then require the isolation of acid-fast bacilli, the ﬁnding
of typical caseating granuloma on biopsy, or the recovery of
tubercle bacilli from the culture of the biopsy material [17].
TB progress insidiously in ERSD patients. The most com-
mon symptoms are non speciﬁc and mimic uraemia (such as fe-
ver, malaise and weight loss) [14].
We have found in our study one patient in group I and
another one in group III with normal plain chest X-ray and
sputum ZN +ve for acid fast bacilli (Table 6). Pulmonary
TB in the presence of a normal chest X-ray has been reported
previously [18]. A normal chest radiograph has a high negative
predictive value for the presence of active TB. However, the
frequency of false-negative examinations is approximately
1% in the adult immunocompetent population and increases
to 7–15% in HIV-seropositive individuals [19]. Darcy et al.,
had found that the incidence of smear-positive pulmonary
TB with a normal chest radiograph was 61% in the period
from 1988 to 1989 and steadily increased to 10% in the period
from 1996 to 1997 [20].Conclusion
Patients with chronic renal failure are at increased risk for
pulmonary and extra pulmonary tuberculosis and should be
screened routinely and carefully for early detection of TB
infection.Conﬂict of interest
None declared.
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